Table:
begin	end	state
1	36	signal peptide
37	63	non-cytoplasmic
64	85	transmembrane
86	96	cytoplasmic
97	119	transmembrane
120	124	non-cytoplasmic
125	144	transmembrane
145	149	cytoplasmic
150	175	transmembrane
176	180	non-cytoplasmic
181	201	transmembrane
202	204	cytoplasmic
205	224	transmembrane
225	242	non-cytoplasmic
243	272	transmembrane
273	283	cytoplasmic
284	302	transmembrane
303	311	non-cytoplasmic
312	331	transmembrane
332	354	cytoplasmic
355	378	transmembrane
379	396	non-cytoplasmic
397	418	transmembrane
419	428	cytoplasmic
429	449	transmembrane
450	454	non-cytoplasmic
455	474	transmembrane
475	485	cytoplasmic
486	510	transmembrane
511	522	non-cytoplasmic
523	546	transmembrane
547	572	cytoplasmic
573	596	transmembrane
597	614	non-cytoplasmic
615	633	transmembrane
634	643	cytoplasmic
644	661	transmembrane
662	663	non-cytoplasmic

Input:
>H281DRAFT_04922
MNRPTATVAFAAPRAWRLPALLLMLAAWLVYHTLSARLPVAQWPGVVLSGADATLQQLVV
RYGWLPRVAIALIAGAALSLAGVVFQQVLRNPLAEPLTLGVSAGAYLALTIAAVVAPALV
ADMRFTVALTGAALAMLATMAMTWRKGFAAVSIVLAGMIVNLYCGALSVLLTIVFERSLT
SVFIWGGGSLVQNGWAGVVWLLPRVLACGAAAALLVRPLTLFSLDDGSASQLGMSLAWTR
PVALAIAVILSAFVASAVGVIGFIGLGGPVLARLMGARRLRDQLLWAPLVGALLLAIADQ
AVQSLPGVLGELLPTGAAVALCGGPLLLWMLRRLHVEAPRPASAEHATPRRALRVPVLLL
GGLLVAAVVISLCFSVTMQGWQWTDAQHWSDVWFWRVPRLTASLGAGVMVALAGTILQRV
TGNPMASPDLLGVSGGAMLGMLVAAVVATEPSTPVLLAGSAAGALVCLLTIVTLGRRSGF
APEHVLLAGIAISAFAQAVIMLATASGGAYANLLRPLQYGSTYLIVPATAIAVGVCTVAA
VLVAYLGARWLEILPLGANVADALGVGAQRARLLLLAVAAILTAGATVVIGPMSFVGLMA
PHLARLLGFPRARSQMLVAALIGGLLMVLSDWLGRNMIFPQQMPAGVIATLLGGPYLMWL
LRR

Or try the official Phobius web server, which has a different display

Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server